SEEK - previously known as PepTcell - is a biotechnology company that uses its novel proprietary epitope prediction algorithm to detect new reactive epitopes for major untreated diseases including amongst others Influenza Tuberculosis, Malaria, HIV and Rheumatoid Arthritis. The Company provides both data base services and licenses out patented epitopes to the pharmaceutical and biotechnology sectors.

Based in High Wycombe, Buckinghamshire, United Kingdom, the Company commenced operations in 2004.